CentralPoint
Foghorn Therapeutics exec sells over $116k in company stock, a move that has sparked curiosity and raised questions about the company’s future. The sale, which occurred on [Date of Sale], involved [Number of Shares] shares at a price of [Price Per Share], totaling over $116,000. While this transaction might seem …
Read More »Foghorn Therapeutics Exec Sells Over $116k in Company Stock
